Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)
China · Delayed Price · Currency is CNY 31.74
+0.95 (3.09%)
At close: Apr 1, 2026
SHA:688161 Revenue
In the year 2025, Shandong Weigao Orthopaedic Device had annual revenue of 1.52B CNY with 4.82% growth. Shandong Weigao Orthopaedic Device had revenue of 416.53M in the quarter ending December 31, 2025, with 12.75% growth.
Revenue
1.52B
Revenue Growth
+4.82%
P/S Ratio
8.28
Revenue / Employee
737.07K
Employees
2,020
Market Cap
12.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.52B | 70.08M | 4.82% |
| Dec 31, 2024 | 1.45B | 169.17M | 13.18% |
| Dec 31, 2023 | 1.28B | -774.42M | -37.63% |
| Dec 31, 2022 | 2.06B | -95.57M | -4.44% |
| Dec 31, 2021 | 2.15B | 329.77M | 18.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Weigao Blood Purification Products | 3.77B |
| Cofoe Medical Technology | 3.39B |
| Qingdao Haier Biomedical Co.,Ltd | 2.33B |
| SonoScape Medical | 2.07B |
| Jafron Biomedical | 2.04B |
| INKON Life Technology | 1.89B |
| MeHow Innovative | 1.63B |
| Shanghai MicroPort Endovascular MedTech | 1.35B |